Speaker Lætitia H. Delmau is th recipient of the prestigious 2024 Glenn T. Seaborg Actinide Separations Award.

M, which are medical radioisotopes used in procedures to diagnose and detect diseases including heart disease and cancer, are ...

Due to the fact that the radioisotopes used to power nuclear batteries are generally produced in nuclear reactors, ...

Bruce Power has set out its plans to expand production of medical radioisotopes in its Candu reactors. As well as increasing ...

Shortages may amount to 40% of the usual radioisotope requirements. Shortages will vary by geographic region. Stakeholders are advised to communicate with their suppliers. The NMEU was not able to ...

Technetium-99m, a critical nuclear imaging radioisotope, is in short supply and could cause delays or cancellations of over 40,000 medical imaging studies daily in the United States. The global ...

A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a patient with ...

According to the Department of Health there is a worldwide shortage. Radiotherapy, or radioisotope therapy uses small amounts of radiation to provide diagnostic information about the function of a ...

The main growth driver remains the pharmaceutical radioisotope business, while all other main product groups also increased compared to the previous year. The Isotope Products segment generated sales ...

Delmau, recipient of the prestigious 2024 Glenn T. Seaborg Actinide Separations Award and a distinguished radiochemist in the Radioisotope Science and Technology Division at Oak Ridge National ...